This list is based on the watchlists of people on Stock Events who follow HCYT. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
Show more...
FAQ
What is Medovex stock price today?▼
The current price of HCYT is $1 USD — it has increased by +0% in the past 24 hours. Watch Medovex stock price performance more closely on the chart.
What is Medovex stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medovex stocks are traded under the ticker HCYT.
What is Medovex market cap?▼
Today Medovex has the market capitalization of 492,610
What were Medovex earnings last quarter?▼
HCYT earnings for the last quarter are -8.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Medovex revenue for the last year?▼
Medovex revenue for the last year amounts to 453,000 USD.
What is Medovex net income for the last year?▼
HCYT net income for the last year is -10.3M USD.
How many employees does Medovex have?▼
As of April 03, 2026, the company has 8 employees.
In which sector is Medovex located?▼
Medovex operates in the Manufacturing sector.
When did Medovex complete a stock split?▼
The last stock split for Medovex was on June 13, 2022 with a ratio of 1:1000.